Tursi, A., and M. Tiano. “SARS-COV-2 Infection Might Cause Transient Cutaneous Lesions in IBD Patients under Treatment With Adalimumab”. Journal of Gastrointestinal and Liver Diseases, Vol. 30, no. 2, June 2021, pp. 310-1, doi:10.15403/jgld-3572.